Last reviewed · How we verify
NCT06339918
Combined Effects of Kegel Exercises and 4-7-8 Breathing Technique in Primary Dysmenorrhea
NA trial testing KegelExercise in Primary Dysmenorrhea in 28 participants. Completed in 5 October 2024.
20 September 2024
Quick facts
| Lead sponsor | Riphah International University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 28 |
| Start date | 1 April 2024 |
| Primary completion | 20 September 2024 |
| Estimated completion | 5 October 2024 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- KegelExercise
- 4-7-8 breathing technique
Conditions studied
- Primary Dysmenorrhea — all drugs for Primary Dysmenorrhea →
Sponsor
Riphah International University
Who can join
Adults 14 to 26, female only, with Primary Dysmenorrhea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A randomized clinical trial will be conducted at Riphah International University QIE Campus in Lahore, using non-probability convenience sampling with 28 participants. Criteria include women aged 14-26, nulliparous, experiencing primary dysmenorrhea, with normal menstrual cycles and the ability to exercise independently. Group A will receive kegel exercises and 4-7-8 breathing techniques over 8 weeks, while Group B will only receive the breathing technique. Assessments will be done on menstrual cycle days, with follow-ups at weeks 4 and 8 using specific scales. Data will be analyzed using SPSS version 27.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06339918
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Primary Dysmenorrhea
Currently open trials in the same condition.
- NCT07409337 — Self-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms · NA · recruiting
- NCT06995287 — Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysme · Phase 3 · recruiting
- NCT07352982 — Transcutaneous Tibial Nerve Stimulation on Women With Primary Dysmenorrhea · NA · recruiting
- NCT07239232 — "Knee Joint Position Sense and Dynamic Balance in Females With Primary Dysmenorrhea · recruiting
- NCT07314021 — Primary Dysmenorrhea and Mobilization. · NA · active not recruiting
Other Riphah International University trials
Trials by the same sponsor.
- NCT07579585 — Effects of Photobiomodulation in Hemophilia Patients. · NA · recruiting
- NCT07504276 — Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors. · NA · recruiting
- NCT07484477 — Sedentary Behavior Modification, Cardiopulmonary Function & QOL Post Cardiac Surgery Patients. · NA · not yet recruiting
- NCT07438587 — Comparative Effects of Cadence Training vs Elliptical Training in Cricketers · NA · not yet recruiting
- NCT07484399 — Comparing Effects of HIIT and MICT on Functional Mobility, Muscle Strength, and Quality of Life in Diabetic Patients · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06339918 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Riphah International University
- Last refreshed: 20 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06339918.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing